Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by Transit77on May 17, 2020 4:09am
272 Views
Post# 31039249

Real & Camo Please elaborate on potential partners and when

Real & Camo Please elaborate on potential partners and when This will occur. I still don't see much mention or specifics on partners for Ryplazim. Also how confident are you that this has that $50-$100 price range. I mean shouldn't it trade higher given such a low float? Please give me a direct answer no re posting of the usual info. Just an educated answer. I don't quite see who would partner and what will happen as a strong catalyst for us? I mean what is resubmitting BLA worth price wise what is a partnership worth price wise and what are the odds of getting this FDA approval ? And post approval what can we expect??? 
<< Previous
Bullboard Posts
Next >>